GlassScriptPhysician profile
Colleen A Deturk
NPI 1801873062
$3,619.30
in general payments reported to CMS, 2019-2025
17 companies · $455 in 2025
The $455 reported for 2025 was more than what 80% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $58.85 · 2022: $676 · 2023: $755 · 2024: $1,675 · 2025: $455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,070 · Travel and Lodging: $715 · Education: $84.99 · Entertainment: $15.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,069.59 |
| Travel and Lodging | $714.60 |
| Education | $84.99 |
| Entertainment | $15.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,341.35 | 2022-2024 | Axonics |
| Medtronic, INC. | $560.55 | 2021-2025 | Interstim, Altaviva |
| Astellas Pharma US INC | $431.45 | 2022-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $313.05 | 2023-2025 | Gemtesa |
| Abbvie INC. | $235.42 | 2024-2025 | |
| Millicent US INC | $141.35 | 2023-2025 | Intrarosa, Femring |
| Mission Pharmacal Company | $119.15 | 2022-2024 | Uribel, Uribel Tabs |
| Coloplast Corp | $118.65 | 2023-2025 | Restorelle |
| Urovant Sciences INC | $80.40 | 2022 | |
| Boston Scientific Corporation | $68.43 | 2024-2025 | Axonics, Advantage System, Bulkamid |
| Therapeuticsmd, INC. | $59.56 | 2021-2022 | |
| Pfizer INC. | $51.48 | 2021-2022 | |
| Sage Therapeutics, LLC | $24.55 | 2025 | Zurzuvae |
| Bluewind Medical | $23.80 | 2024 | Revi |
| 180 Medical, INC. | $21.91 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Provepharm INC. | $15.33 | 2024 | Bludigo |
| Hologic Sales and Service, LLC | $12.87 | 2023 | Omni Hysteroscope |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colleen Deturk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.